by the G gene (1674 bases) located in the lipid bilayer of the virus protruding as spikes. It participates in many important processes for virus replication and mediates the entry of the virus inside the host cell through endocytosis as well as entry into the central nervous system. It binds to many host cellular receptors such as myocytes, neurons, and acini, which helps in the attachment to the viral envelope to the host endosomal membrane. Other processes it carries out are apoptosis, protecting the virus from the host's immune response, and axonal transport of the virus after invasion into the host cell making it a very important target in structure-based drug designing. Being an important protein responsible for the virus entry and replication, it is also an antigen activator protein eliciting an immune response and is used to produce commercial rabies vaccine. Thus, by inhibiting this protein using anti-rabies phytochemical compounds, we can stop the viral entry and further replication of the virus inside the host. [5, 7] Considering the importance of glycoprotein G for the virus entry and replication, the protein was chosen for the study and modeled as no proper structure for this protein exists in the protein structure database (PDB).
Available treatment and vaccines
Only seven people have survived rabies to date as there is no medication available postexposure to the virus also known as postexposure prophylaxis. In the case of postexposure prophylaxis, to prevent a person's chance of developing clinical symptoms, the only treatment that can be done is cleaning the wound, administration of rabies vaccine, and human rabies immunoglobulin to the patient. The survival depends on how quickly the vaccine is administered after exposure. Vaccines Imovax Rabies and RabAvert are the only two vaccines manufactured for use and are available in the United States. Administration of these vaccines also has side effects which include itching, swelling, and redness at the site of injection. [3, 8] Being labeled as a neglected tropical disease by the WHO, rabies is rampant in developing nations and mostly affects people in the rural region. There is a severe lack of awareness and contribution of government and health-care bodies to invest time and money for the management of rabies as well as for researching newer medications against the disease mainly because it affects people of lower socioeconomic class. [2] Phytochemical-based treatment against rabies Natural treatment which includes phytochemicals is being studied and used since ancient times for the treatment of many ailments by people specifically in Asia. It is reported that about 25% of all drugs have plant-based origins. Phytochemicals derived from plants are studied to have antiviral potential and can inhibit virus replication. The major advantage of using plant-based drugs is that they have very few to no side effects when used while treating the patient in contrast to conventional drugs which are observed to have toxicity and severe side effects. The other advantage is the abundance of medicinal plant species reported worldwide around 2500 species exist. [9] Considering these factors, naturally derived products that are phytochemicals were investigated for studying if they have any affinity against the glycoprotein G of the rabies virus.
Phytochemicals isolated from plant Salix subserrata were proven through in vitro studies to have anti-rabies activity. These phytochemicals included flavonoids such as (+)-catechin, 1,2-benzenedicarboxylic acid, bis (2-ethylhexyl) ester, saligenin, methyl 1-hydroxy-6-oxocyclohex-2-enecarboxylate, catechol, propyl acetate, β-sitosterol, and β-sitosterol glucopyranoside. [10] Similarly, In another study, flavonoids, kaempferol, and quercetin from onion were reported to have anti-rabies activity. [11] The aim of the study was to model glycoprotein G and dock it using two different algorithms that are software AutoDock Vina (Molecular Graphics Laboratory, The Scripps Research Institute, La Jolla, California, United States) and server SwissDock to analyze the binding site and binding affinity using ten phytochemicals from the literature showing anti-rabies activity; they were used in the in silico docking study to find a potential natural drug against the rabies virus after they pass the toxicity filters of SwissADME and Protox-II servers. Currently, there is an urgent need to develop safer alternatives for rabies, as this disease is extremely fatal and postinfection with the virus always results in the death of the patient.
metHods

Modeling of the target protein
The target protein for rabies, that is, glycoprotein G, has no proper structure in the PDB database; its sequence was retrieved from Swiss-Prot, having UniProt id-P03524, [12] and submitted on Robetta server to build the protein structure. [13] Robetta is a fully automated method that builds the model protein using comparative modeling in which structure is parsed into domains, and models are built by searching homologous structure using Blast, Psi-Blast, and 3D-Jury which will be used as a template. The server accepts the target protein sequence as the input, and the result generated is mailed to the user. [14] The structure was downloaded and visualized in the Discovery Studio Visualizer. [15] 
Energy minimization
ModRefiner is an energy minimization server which was used to perform energy minimization of the protein structure. The server performs the energy minimization process through a lower resolution refinement of protein followed by the building of side-chain rotamers. The server requires a protein structure submitted in PDB format. [16] 
Protein validation using Rampage
The energy-minimized structure was downloaded and validated by submitting it on the Rampage server. The protein structure both before and after energy minimization was submitted simultaneously on Rampage to validate and check how energy minimization improved the overall quality of the structure. The Ramachandran plot includes information about the number of amino acid residues present in the allowed region and favored regions. The server also predicts outlier residues present in the protein structure, if any. [17] 
Active site prediction
The target protein against rabies, that is, glycoprotein G, was submitted on 3DLigandSite, MetaPocket 2.0 server, and RaptorX-Binding Site. 3DLigandSite predicts the active site of the submitted structure by comparing with ligands bound to the homologous structure to the query structure; MetaPocket 2.0 uses eight prediction methods that are LIGSITEcs, PASS, Q-SiteFinder, SURFNET, Fpocket, GHECOM, ConCavity, and POCASA to identify the active sites on the protein structure; and Raptor-X accepts protein sequence as input, builds a structure, and predicts active site based on similar pockets occurring in homologous structure in PDB database. [18] [19] [20] 
Ligand preparation and drug-likeness prediction
Ten anti-rabies phytochemicals from plants Salix subserrata and onion were selected based on literature studies. MarvinSketch software was used to draw the structure of selected phytochemicals. Then explicit hydrogens were added to the structures from the add hydrogen option. The structures were cleaned in 2D and 3D using the 'Clean 2D' and 'Clean 3D' option in MarviSketch, and the structures were saved in SMILES and PDB formats. [21] The ligands were submitted in SMILES format on SwissADME and Protox-II servers. SwissADME is a server which predicts whether a compound has potential to be drug-like by checking various properties and filters of the submitted compound which includes physicochemical properties such as molar mass, hydrogen donor, acceptor, log P value, pharmacokinetic properties (gastrointestinal [GI] absorption), water solubility, and topological polar surface area (TPSA). [22] Protox-II server is a free in silico toxicity predictor which predicts the lethal dose 50 (LD 50 ) value in mg/kg body weight, according to which the server has classified the six classes into which the drug can fall depending on its predicted LD 50 value. Class 6 is nontoxic and safe for consumption. LD 50 is the dose at which 50% or half of the test population will die upon exposure to a compound. The server accepts input in SMILES format and also by drawing through its embedded structure drawing plugin on the site. After submission, the results are returned as the predicted LD 50 value in mg/kg weight, the prediction accuracy in percentage, and the similarity of the input compound with other similar toxic compounds from the dataset with known rodent oral toxicity values. [23] 
Docking preparation
AutoDock Vina and SwissDock were used to carry out the in silico docking analysis, whereas AutoDock Tools were used to generate the input files for docking using AutoDock Vina. [24] [25] [26] For AutoDock Vina, the input required was generated using AutoDock Tools that were the pdbqt files of the ligands, protein target, and the configuration file containing dimensions of the grid box that is x, y, and z coordinates. The target protein in PDB format was loaded in MGLTools, the water molecules were deleted, and nonpolar hydrogen was added; it was then saved in pdbqt format. Active site residues predicted by the three servers were selected of the protein, and the grid box around these active sites was made in order to direct the algorithm about the position of the active site residues, using spacing of 1 angstrom, the grid box was made, and the coordinate values were: center_x = −7.106, center_y = 32.915, center_z = 13.673, size_x = 60, size_y = 50, and size_z = 56 were typed and saved in a configuration file, along with protein and ligand filename. The ligand molecule in PDB format was then loaded, and all its nonrotatable bonds were made rotatable using the choose torsion option in the ligand menu of AutoDock Tools; the Gasteiger charges were added, and the file was saved in pdbqt format. On completion of docking, AutoDock Vina generated the outfile which gives the nine different poses by which the ligand binds to the target protein and the log file which has the binding energy and root-mean-square deviation values of the ligand binding to the target protein.
Docking analysis using the SwissDock server was carried out, by submitting the target protein in PDB format and the ligands in mol2 format. SwissDock allows the user to edit advance parameters and gives the grid space inputs which include the center x, y, z and size x, y, z values. The values used for these parameters were the same as AutoDock Vina to compare and validate the docking results. The results are generated as zip files which can be extracted to view the different docking poses of the ligand with the protein, and the server also has inbuilt JSMOL viewer to view the binding pose of the ligands.
The 2D and 3D protein-ligand interactions of the results generated by AutoDock Vina and SwissDock were visualized in Discovery Studio Visualizer; the software also gives the type of interaction with which the ligand binds to the protein. [15] results
Energy minimization and protein validation using Rampage server
The target glycoprotein G of rabies virus was chosen for the study cause of its importance in viral replication for the docking analysis, as there is no 3D structure of the protein and its modeling was carried out. After submission of Swiss-Prot sequence id-P03524 on Robetta, the modeled protein obtained was downloaded and visualized in Discovery Studio Visualizer, as shown in Figure 1 .
After modeling, energy minimization was carried out using the ModRefiner server on the modeled protein. The energy minimized refined protein file, as well as the original modeled protein file, was validated on the Rampage server to check the Ramachandran plot. The resulting output is the number of residues in the allowed regions, favored region, and outliers summarized in Table 1 of the modeled protein structure for before and after the energy minimization step.
The Ramachandran plot maps the psi versus phi backbone angles for each amino acid residue in a protein structure. This plot thus gives essential information about the conformation and folding of a protein structure. [17] The results are shown as number of residues in the allowed region, which should be around 98%, number of residues in the favored region -expected value is around 2%, and the number of outlier residues which should be zero. Target protein followed the Rampage plot after energy minimization having residues in the desirable range of allowed and favored regions, as shown in Table 1 . The results showed that the energy minimization process improved the overall quality and stability of the structure. The number of residues in the allowed and favored regions also increased and now after minimization was in the acceptable range of the Ramachandran plot, whereas the number of outliers before the energy minimization of the protein was four outliers which decreased to 1 outlier that is glycine in the final result.
Glycine does not follow the Ramachandran plot as it has no side chain; thus, it can adopt the psi and phi angles in any region of the plot and is frequently found in an allowed region or as an outlier where other residues should not fall. Hence, having glycine residues as an outlier is acceptable while docking and selection of active site having no impact on the final result. [27] The modeled protein following the expected range of Ramachandran plot can thus be deemed as a stable protein structure.
Active site results
The active site of glycoprotein G of the rabies virus was submitted on servers 3DLigandSite, MetaPocket, and RaptorX-Binding Site, and the predicted sites by these servers are summarized in Table 2 .
All the three servers have different algorithms, and their combined results give us the increased probability of where the binding pockets are located in the protein structure.
SwissADME and Protox-II results for phytochemicals
The anti-rabies phytochemicals from the plants Salix subserrata and onion were first drawn on Marvin Sketch, cleaned in 2D and 3D, and then, their SMILES format was submitted to the SwissADME server and Protox-II to check if they have potential properties to be a drug-like compound. After submitting ten ligands, the two ligands that passed all the SwissADME and Protox-II filters were (+)-catechin and kaempferol whose chemical figures are shown in Figure 2a and b.
The ligands were checked for their Lipinski's rule of five properties, TPSA, water solubility, and gastrointestinal absorption. The Lipinski's filter of five states that for a molecule to be considered drug-like and orally bioavailable, it should pass four different physiochemical parameters (molecular weight ≤ 500, log P ≤ 5, H-bond donors ≤ 5, H-bond acceptors ≤ 10); both the ligands (+)-catechin and kaempferol passed these four parameters predicted by SwissADME. [28] TPSA is shown to be a very important property for drug-like molecule influencing drug absorption, intestinal absorption, bioavailability, and blood-brain barrier penetration and should be less than 140 Å 2 . [29, 30] The SwissADME results are summarized in Table 3 .
The Protox-II results are shown in Table 4 . (+)-Catechin had an LD 50 value of 10,000 mg/kg which was predicted belonging to Class 6 of Protox classification. Kaempferol had an LD 50 value of 3919 mg/kg and predicted to be a Class 5 compound. Compounds belonging to Classes 5 and 6 are relatively safe for consumption and nontoxic, specifically LD 50 value of above than 5000 mg/kg (Class 6) is labeled as the safest nontoxic class of compounds for oral consumption which will thus have no side effects in a patient, and LD 50 value (2000 < LD 50 ≤ 5000 mg/kg) is classified as Class 5 compound. [31] 
Docking analysis
The receptor glycoprotein G of rabies virus was docked using the two ligands: (+)-catechin and kaempferol which passed the in silico toxicity tests of the SwissADME and Protox-II parameters. The output of the docking carried out using AutoDock Vina and SwissDock was the free binding energy, full fitness (kcal/mol), and estimated ΔG (kcal/mol) with which the ligand binds to the pocket of the receptor protein.
The docking results of the ligands are summarized in Table 5 .
For docking carried out using AutoDock Vina, the best conformation of glycoprotein G with (+)-catechin complex with binding energy (−8.0 kcal/mol) was visualized in Discovery Studio; the 2D interaction of the residues of the protein-ligand complex is shown in Figure 3a and 3D interaction in Figure 3b . The ligand formed conventional hydrogen bonds with the residue proline-15.
Similarly, the best conformation of glycoprotein G with kaempferol complex with binding energy (−7.5 kcal/mol) was visualized in Discovery Studio; the 2D interacting residues of the protein-ligand complex are shown in Figure 4a and 3D interaction in Figure 4b . No residues formed a conventional hydrogen bond with the ligand.
SwissDock results observed in Discovery Studio for glycoprotein G with ligand (+)-catechin are shown in Figure 5a and b. The ligand formed a conventional hydrogen bond with the residue alanine-419 of the protein, while for glycoprotein G with kaempferol interaction, as shown in Figure 6a and b, no conventional hydrogen bonds were formed.
Ligand (+)-catechin gave better binding affinity score, while docking using AutoDock Vina and better full fitness and estimated ΔG (kcal/mol) values in SwissDock than the ligand kaempferol [ Table 5 ].
dIscussIon
Glycoprotein G of the rabies virus is an essential protein in the pathogenesis of the viral disease inside the host, aside from that it is the choice of the target while designing rabies vaccines. Glycoprotein G interacts with the cellular receptor, and this interaction allows the virus to gain entry inside the host where this protein mediates endocytosis of the virus along with other essential functions required for virus replication and virulence. [32, 33] Considering these factors, the protein was chosen for the study and modeled. The energy minimization step improved the overall quality of the modeled protein by reducing the number of outliers. The phytochemicals exhibiting in-vitro anti-rabies activity were reviewed from literature studies as discussed below.
Meresa et al. reviewed plants which have anti-rabies activity and are used for the treatment of rabies in Ethiopia. In this study, plant Salix subserrata was reviewed to be having anti-rabies activity. Important active phytochemicals isolated from the plants include (+)-catechin, 1,2-benzenedicarboxylic acid, bis (2-ethylhexyl) ester, saligenin, methyl 1-hydroxy-6-oxocyclohex-2-enecarboxylate, catechol, propyl acetate, β-sitosterol, and β-sitosterol glucopyranoside from the plant. [10] The antiviral activity of the plant Salix subserrata was studied in vitro by Deressa et al. (2010) . Mice inoculated with rabies virus were administered chloroform and aqueous crude leaf extract of Salix subserrata. Chloroform and aqueous extracts of Salix subserrata showed significant anti-rabies activity by significantly increasing the survival time of the mice. [34] Kaempferol and quercetin isolated from onion are flavonoids, which have shown antiviral activity by inhibiting the growth of several viruses including the rabies virus. Many studies have proved the potential of flavonoids in the inhibition of viruses. [11, 35] After submitting ten reviewed phytochemicals from the above studies, ligands (+)-catechin and kaempferol were predicted to be drug-like molecules by the SwissADME server. The GI absorption and water solubility filters were passed by the Water solubility is an important parameter because when a drug is poorly soluble, the dosage required of the drug administered to the patient orally would be much higher. Hence, higher solubility is required for a drug to elicit a pharmacological response as it will reach higher solubilized levels in the plasma quickly. [36] These predictions indicate that ligands have drug-like properties and have the potential to be an oral drug. The phytochemicals (+)-catechin and kaempferol further passed the in silico toxicity filters of the Protox-II server, which indicate that they be further used as a potential anti-rabies drug and were further subjected for the docking studies.
Docking studies were carried out using the same grid dimensions in both AutoDock Vina and SwissDock to compare the docking studies. After docking using AutoDock Vina, both the ligands showed similar binding residues which were residue no proline-15, leucine-16, glycine-19, lysine-20, phenylalanine-21, histidine-403, tryptophan-456, and tyrosine-459. Similarly, after docking using SwissDock, both the ligands showed similar binding residues which were residue leucine-414, leucine-418, alanine-419, aspartate-420, proline-421, valine-424, phenylalanine-434, valine-437, valine-442, serine-447, leucine-461, leucine-462, glycine-465, alanine-466, and alanine-469. These residues can be considered as important interacting sites of the protein structure as both the ligands interacted and formed bonds with these specific residues only.
As there are no standard drugs available for rabies in the market, there is an urgent need for a drug with fewer side effects for helping the management of the disease, and the ligand (+)-catechin can be considered as a potent natural drug against rabies, considering the results that it showed more binding affinity, full fitness, and estimated ΔG values using both AutoDock Vina and SwissDock toward the glycoprotein G while forming conventional hydrogen bond with the residues proline-15 and alanine-419 of the target protein while kaempferol did not form any hydrogen bond. Hydrogen bonds contribute to protein-ligand binding by enhancing the ligand-binding affinity through the displacement of protein-bound water molecules. They are also known to contribute to the stability of the protein-ligand complex. [37] Natural compound-derived drugs are known for their nontoxic and effective nature against various viruses; rabies has been affecting people all around the world and its nature of being a fatal disease requires immediate measures to develop safer drug options which can be taken to stop the viral replication inside the host which ultimately leads to death. In this study, both the ligands showed similar binding residues with the target protein, and the study thus gave insight about which active site residues of the protein are more important for binding of a ligand. Ligand (+)-catechin gave better scores than kaempferol using both docking programs AutoDock Vina and SwissDock, thus validating the docking scores making it a viable option to be used as a natural source of the anti-rabies drug. This study thus facilitated the importance of phytochemical-based drug discovery to help people affected by rabies.
conclusIon
Protein modeling and docking analysis using AutoDock Vina and SwissDock of glycoprotein G, a protein target against the fatal rabies disease, was performed using selected phytochemicals. Glycoprotein G was selected as the virus target, after studying the importance of the protein and its importance in entry and virus replication. After modeling this protein, ten phytochemicals were screened for various properties including the physiochemical properties, pharmacokinetic properties (GI absorption), water solubility, Log P values, TPSA, and LD 50 (lethal dose) after which only two ligands (+)-catechin and kaempferol passed all these filters they were used for the docking analysis against modeled protein. The two phytochemicals that were (+)-catechin and kaempferol which satisfied all the filters on the SwissADME and Protox-II sever were used in docking analysis. Ligand (+)-catechin gave better binding affinity than kaempferol toward the target glycoprotein G in AutoDock Vina and also gave better full fitness and estimated ΔG values using SwissDock and thus was proved here to be a potential natural inhibitor against the rabies virus.
